Renée L. DesJarlais

Author

Renée L. DesJarlais

Also Known As

R L DesJarlais, R. L. DESJARLAIS, R. L. Desjarlais, R.L. DesJarlais, Renee DesJarlais, Renee L DesJarlais, Renee L. DesJarlais, Renee L. Desjarlais, Renée L Desjarlais, Renée L. DesJarlais

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Johnson & Johnson (United States)New Frontier Janssen (United States)Springhouse Janssen (Belgium)

About

Renée L. DesJarlais is an author at Johnson & Johnson (United States) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	40	2K
2	Natural Sciences	21	29	1.5K
3	Biochemistry	21	30	1.7K
4	Engineering	1	1	17
5	Allergy	1	1	32

Renée L. DesJarlais

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure Renée L. DesJarlais, Robert P. Sheridan, George Seibel, Journal of Medicinal Chemistry	1988	404
Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease. Renée L. DesJarlais, George Seibel, Irwin D. Kuntz, Proceedings of the National Academy of Sciences Crystal StructureMolecular BiologyAntiviral DrugChemical BiologyMedicinal Chemistry	1990	254
Docking flexible ligands to macromolecular receptors by molecular shape Renée L. DesJarlais, Robert P. Sheridan, Jonathan S. Dixon, Journal of Medicinal Chemistry BiochemistryProtein FoldingMedicineTest CaseRational Drug Design	1986	248
Current and Future Roles of Artificial Intelligence in Medicinal Chemistry Synthesis Thomas J. Struble, Juan C. Alvarez, Scott P. Brown, Journal of Medicinal Chemistry	2020	236
Comparison of Automated Docking Programs as Virtual Screening Tools Maxwell D. Cummings, Renée L. DesJarlais, Alan C. Gibbs, Journal of Medicinal Chemistry	2005	205
Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolution Céline Schalk‐Hihi, Carsten J. Schubert, Richard Alexander, Protein Science Crystal StructureProteinlipid InteractionHuman Monoglyceride LipaseClosed ConformationLipid Movement	2011	127
Design of potent and selective human cathepsin K inhibitors that span the active site Scott K. Thompson, Stacie M. Halbert, Mary J. Bossard, Proceedings of the National Academy of Sciences Bioorganic ChemistryAldo-keto ReductaseMolecular BiologyChemical BiologyMedicinal Chemistry	1997	119
Structure and Design of Potent and Selective Cathepsin K Inhibitors Dennis S. Yamashita, Ward W. Smith, Baoguang Zhao, Journal of the American Chemical Society Molecular RecognitionMolecular PharmacologyMedicinal ChemistryProtein BiochemistryBiochemistry	1997	106
Synthesis of thiophene-2-carboxamidines containing 2-amino-thiazoles and their biological evaluation as urokinase inhibitors Kenneth J. Wilson, Carl R. Illig, Nalin L. Subasinghe, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryUrokinase InhibitorsMedicineNatural Sciences	2001	98
Determination of the Amino Acid Residue Involved in [3H]β-Funaltrexamine Covalent Binding in the Cloned Rat µ Opioid Receptor Chongguang Chen, Jinling Yin, J. Kim de Riel, Journal of Biological Chemistry	1996	83

Page 1